Substrate stiffness and the receptor-type tyrosine-protein phosphatase alpha regulate spreading of colon cancer cells through cytoskeletal contractility
KRNDIJA, D, SCHMID, H, EISMANN, J.-L, LOTHER, U, ADLER, G, OSWALD, F, SEUFFERLEIN, T, VON WICHERT, G
Published in Oncogene (06.05.2010)
Published in Oncogene (06.05.2010)
Get full text
Journal Article
CUTL1 promotes tumor cell migration by decreasing proteasome-mediated Src degradation
ALEKSIC, T, BECHTEL, M, KRNDIJA, D, VON WICHERT, G, KNOBEL, B, GIEHL, K, GRESS, T. M, MICHL, P
Published in Oncogene (30.08.2007)
Published in Oncogene (30.08.2007)
Get full text
Journal Article
Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer: AIO KRK 0205
HOEHLER, T, VON WICHERT, G, HALLEK, M, HOFHEINZ, R, HACKER, U. T, SCHIMANSKI, C, KANZLER, S, MOEHLER, M. H, HINKE, A, SEUFFERLEIN, T, SIEBLER, J, HOCHHAUS, A, ARNOLD, D
Published in British journal of cancer (17.09.2013)
Published in British journal of cancer (17.09.2013)
Get full text
Journal Article
1259 Trabedersen (AP 12009) in the treatment of pancreatic carcinoma and other malignant tumors: interim results of the Phase I/II study
Oettle, H, Hilbig, A, Seufferlein, T, Luger, T, Schmid, R.M, Von Wichert, G, Heinrichs, H, Schlingensiepen, K.H
Published in European journal of cancer supplements (2009)
Published in European journal of cancer supplements (2009)
Get full text
Journal Article
Palliative treatment of pancreatic cancer
Seufferlein, T, von Wichert, G, Adler, G
Published in Deutsche medizinische Wochenschrift (13.04.2007)
Published in Deutsche medizinische Wochenschrift (13.04.2007)
Get more information
Journal Article
Sphingosylphosphorylcholine regulates keratin network architecture and visco-elastic properties of human cancer cells
Seufferlein, Thomas, Beil, Michael, Micoulet, Alexandre, von Wichert, Götz, Paschke, Stephan, Walther, Paul, Omary, M. Bishr, Van Veldhoven, Paul P, Gern, Ulrike, Wolff-Hieber, Elke, Eggermann, Juliane, Waltenberger, Johannes, Adler, Guido, Spatz, Joachim
Published in Nature cell biology (01.09.2003)
Published in Nature cell biology (01.09.2003)
Get full text
Journal Article
A 31-year-old pregnant woman with refractory hypercalcemia
Kühn, M W M, Blagieva, R, Beha, D, Hänle, M, Reister, F, Henne-Bruns, D, Pilcher, C, Böhm, B O, von Wichert, G
Published in Der Internist (Berlin) (01.12.2012)
Published in Der Internist (Berlin) (01.12.2012)
Get full text
Journal Article
Protein kinase D2 regulates chromogranin A secretion in human BON neuroendocrine tumour cells
von Wichert, G., Edenfeld, T., Adler, G., Seufferlein, T.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
Trabedersen (AP 12009) in the treatment of patients with advanced tumors: Completion of dose-escalation and first efficacy data
Oettle, H., Hilbig, A., Seufferlein, T., Luger, T., Schmid, R. M., von Wichert, G., Schmaus, S., Heinrichs, H., Schlingensiepen, K.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
Insulin-like growth factor-I is an autocrine regulator of chromogranin A secretion and growth in human neuroendocrine tumor cells
VON WICHERT, G, JEHLE, P. M, HOEFLICH, A, KOSCHNICK, S, DRALLE, H, WOLF, E, WIEDENMANN, B, BOEHM, B. O, ADLER, G, SEUFFERLEIN, T
Published in Cancer research (Chicago, Ill.) (15.08.2000)
Get full text
Published in Cancer research (Chicago, Ill.) (15.08.2000)
Journal Article
Role of the regulatory domain of protein kinase D2 in phorbol ester binding, catalytic activity, and nucleocytoplasmic shuttling
Auer, Alexandra, von Blume, Julia, Sturany, Sabine, von Wichert, Götz, Van Lint, Johan, Vandenheede, Jackie, Adler, Guido, Seufferlein, Thomas
Published in Molecular biology of the cell (01.09.2005)
Published in Molecular biology of the cell (01.09.2005)
Get full text
Journal Article
Phase I/II trial of capecitabine (Cap) and oxaliplatin (Ox) in combination with bevacizumab (Bev) and imatinib (Ima) in patients with metastatic colorectal cancer (CRC): AIO KRK 0205
von Wichert, G., Hoehler, T., Schimanski, C. C., Moehler, M. H., Hofheinz, R., Kanzler, S., Hinke, A., Seufferlein, T., Siebler, J., Hochhaus, A., Arnold, D., Hallek, M., Hacker, U. T.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Phase I/II study with trabedersen (AP 12009) monotherapy for the treatment of patients with advanced pancreatic cancer, malignant melanoma, and colorectal carcinoma
Oettle, H., Hilbig, A., Seufferlein, T., Tsianakas, A., Luger, T., Schmid, R. M., von Wichert, G., Endlicher, E., Garbe, C., Kaehler, K. K., Hauschild, A., Enk, A., Kiessling, P., Schmaus, S., Heinrichs, H., Schlingensiepen, K.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Interim results of the phase I/II study of trabedersen (AP 12009) in patients with pancreatic carcinoma, malignant melanoma, or colorectal carcinoma
Oettle, H., Hilbig, A., Seufferlein, T., Schmid, R. M., Luger, T., von Wichert, G., Schmaus, S., Heinrichs, H., Schlingensiepen, K.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article